home / stock / vect / vect news

VECT News and Press, VectivBio Holding AG From 06/29/22

Stock Information
Company Name: VectivBio Holding AG
Stock Symbol: VECT
Market: NASDAQ
Website: vectivbio.com
Menu
VECT VECT Quote VECT Short VECT News VECT Articles VECT Message Board
Get VECT Alerts

News, Short Squeeze, Breakout and More Instantly...
VECT - VectivBio Announces Closing of $54 Million Aggregate Financing

BASEL, Switzerland, June 29, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, announces it has closed each of its previously announced...
VECT - REV, CPS and GBOX among mid-day movers

Gainers: Sidus Space (SIDU) +94%. Evoke Pharma (EVOK) +50%. Visionary Education Technology Holdings (VEDU) +37%. Heliogen (HLGN) +27%. Ribbon Communications (RBBN) +25%. Digital World Acquisition (DWACW) +22%. Wheels Up Experience (UP) +21%. Austin Gold (AUST) +21%. AeroClean Technologies (AE...

VECT - Evoke, Zynerba top healthcare gainers; while 180 Life, Belite Bio lead losers' pack

Gainers: Evoke Pharma EVOK +52%. Zynerba Pharmaceuticals (ZYNE) +18%. LifeMD (LFMD) +13%. Vivos Therapeutics (VVOS) +12%. ACADIA Pharmaceuticals ACAD +11%. Losers: 180 Life Sciences (ATNF) -31%. Belite Bio (BLTE) -19%. VectivBio VECT -14%...

VECT - VectivBio prices $30M follow-on stock offering

VectivBio Holding (NASDAQ:VECT) has priced a follow-on public offering of 5.72M ordinary shares at a price of $5.25/share for aggregate gross proceeds of ~$30M. Underwriters are granted a 30-day option to purchase up to an additional 857,250 ordinary shares at the public offering price. Offer...
VECT - VectivBio Announces Pricing of $30 Million Public Offering of Ordinary Shares

BASEL, Switzerland, June 14, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the pricing of a follow-on public offeri...

VECT - VectivBio launches public offering of shares, ~$20M private placement transaction

Clinical-stage biopharmaceutical company VectivBio Holding launched a follow-on public offering of ordinary shares and agreed to sell ~$20M worth ordinary shares to Forbion Growth Opportunities Fund II Coöperatief U.A. in a private placement transaction. For the public offering, size not...

VECT - VectivBio Announces Launch of Public Offering of Ordinary Shares

BASEL, Switzerland, June 14, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the launch of a follow-on public offerin...
VECT - VectivBio Publishes Invitation to the Annual General Meeting

BASEL, Switzerland, June 09, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today published the invitation to the 2022 Annual Genera...

VECT - VectivBio Announces First Two Patients Dosed in Phase 2 STARGAZE Study of Apraglutide for the Treatment of Acute Graft-versus-Host Disease

– Interim proof-of-concept data anticipated from STARGAZE in H1 2023 – First-in-class regenerative, non-immunosuppressive approach to treating acute Graft-versus-Host Disease – Second clinical indication under evaluation for apraglutide, demonstratin...

VECT - BIOX, VECT and BBIO are among after hour movers

Gainers: Palo Alto Networks (PANW) +11%. Bioceres Crop Solutions  (BIOX) +7%. VectivBio Holding AG (VECT) +7%. Aveanna Healthcare Holdings (AVAH) +6%. Fate Therapeutics (FATE) +5%. Losers: Foghorn Therapeutics  (FHTX) -26%. Ross Stores (ROST) -23%. Atara Biotherapeutics (A...
Previous 10 Next 10